Introduction
Leading diagnostic services provider reported Q2 FY26 net profit of ₹47.81 crore, revenue of ₹216.53 crore, and total income of ₹219.58 crore, declaring ₹7/share interim dividend and 2:1 bonus issue.
Share price movement of Thyrocare Technologies
On October 15, 2025, Thyrocare Technologies Ltd opened at ₹1,470.00, up 16.25% from its previous close of ₹1,264.60. The stock reached a high of ₹1,470.00 and a low of ₹1,264.15. By 12:03 PM, it traded at ₹1,274.95, a 0.82% increase, with a market cap of ₹6,756.53 crore.
Thyrocare Reports Strong Q2 FY26 Results
Thyrocare Technologies Limited reported a strong rise in net profit for Q2 FY26, reaching ₹47.81 crore, up 25% quarter-on-quarter from ₹38.29 crore and 81% year-on-year from ₹26.42 crore, reflecting robust business performance.
Revenue from operations increased to ₹216.53 crore in Q2 FY26, marking a 12% rise compared to ₹193.03 crore in Q1 FY26 and a 22% growth over ₹177.36 crore in Q2 FY25, highlighting sustained demand for diagnostic services.
Total income for Q2 FY26 stood at ₹219.58 crore, showing a 11% quarter-on-quarter increase from ₹197.68 crore and 22% year-on-year growth from ₹179.97 crore, driven by higher operational efficiency and expansion across geographies.
The Board declared an interim dividend of ₹7 per share and recommended a 2:1 bonus issue, celebrating its 25th anniversary and rewarding shareholders, subject to regulatory approvals and the record date fixed on October 24, 2025.
Stock performance of Thyrocare Technologies for Period of 1 week, 6 months, and 1 year
Thyrocare Technologies Ltd delivered a 2.73% return over the past week, gained 78.5% in the past six months, and rose 52.6% over the past year.
Shareholding pattern of Thyrocare Technologies
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
| Promoter | 71.10% | 71.10% | 71.10% |
| FII | 4.90% | 3.20% | 2.40% |
| DII | 13.50% | 14.50% | 15.00% |
| Public | 10.60% | 11.20% | 11.60% |
About Thyrocare Technologies
Thyrocare Technologies Ltd (NSE: THYROCARE) operates in the healthcare sector, offering quality diagnostic services at affordable rates to patients, laboratories, and hospitals across India, focusing on reliable, accessible, and efficient healthcare solutions.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Why is Thyrocare Technologies Ltd share price going up today?
A: Thyrocare Technologies Ltd share price rose due to Q2 FY26 net profit of ₹47.81 crore, revenue of ₹216.53 crore, and approved interim dividend, bonus issue.
Q: What does Thyrocare Technologies Ltd specialize in?
A: Thyrocare Technologies Ltd specializes in providing quality diagnostic services to patients, laboratories, and hospitals across India at affordable rates.
Q: What is the market capitalization of Thyrocare Technologies Ltd?
A: The market capitalization of Thyrocare Technologies Ltd is ₹6,756.53 crore as of October 15, 2025.


